FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
Jul 23, 08:45 PM
Share
Subscribe
AP correspondent Haya Panjwani reports on peptides being considered by federal health institutions.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.